Bookmark and Share

6 Oversold Dividend Aristocrats You Need To Know

As the markets snap back from January's lows, income investors are on the lookout for stocks with solid dividend yields that have strong fundamentals and are oversold due to the year's volatility.

Looking at the stocks' technical charts can help determine whether the fundamentals can be further supported. Not surprisingly, this year's market volatility has wreaked havoc on many strong dividend stocks.

Today you will find a couple of Dividend Aristocrats that are oversold on a technical level, the RSI 40 percent.

Only because a stock is oversold is not a bad sign for a long-term dividend growth stocks. I could be a buying opportunity if you believe that the current weakness is also only technical and fundamentals are right.

These are the most oversold Dividend Aristocrats of the recent months....

Target Corporation -- Yield: 3.56% RSI 33.94

Target Corporation (NYSE:TGT) employs 341,000 people, generates revenue of $73,785.00 million and has a net income of $3,321.00 million. The current market capitalization stands at $40.08 billion.

Target Corporation’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $7,124.00 million. The EBITDA margin is 9.66% (the operating margin is 7.49% and the net profit margin 4.50%).

Financials: The total debt represents 31.69% of Target Corporation assets and the total debt in relation to the equity amounts to 98.48%. Due to the financial situation, a return on equity of 24.64% was realized by Target Corporation.

Twelve trailing months earnings per share reached a value of $5.29. Last fiscal year, Target Corporation paid $2.20 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.76, the P/S ratio is 0.54 and the P/B ratio is finally 3.14. The dividend yield amounts to 3.56%.

Stock Charts:


Long-Term Stock Price Chart of Target Corporation (TGT)
Long-Term Stock Price Chart of Target Corporation (TGT)
Long-Term Dividend Payment History of Target Corporation (TGT)
Long-Term Dividend Payment History of Target Corporation (TGT)
Long-Term Dividend Yield History of Target Corporation (TGT)
Long-Term Dividend Yield History of Target Corporation (TGT)



T. Rowe Price Group -- Yield: 3.03% RSI: 31.30

T. Rowe Price Group (NASDAQ:TROW) employs 6,061 people, generates revenue of $4,200.60 million and has a net income of $1,223.00 million. The current market capitalization stands at $17.75 billion.

T. Rowe Price Group’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2,025.20 million. The EBITDA margin is 48.21% (the operating margin is 45.21% and the net profit margin 29.11%).

Financials: The total debt represents 0.00% of T. Rowe Price Group assets and the total debt in relation to the equity amounts to 0.00%. Due to the financial situation, a return on equity of 23.76% was realized by T. Rowe Price Group.

Twelve trailing months earnings per share reached a value of $4.68. Last fiscal year, T. Rowe Price Group paid $2.08 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 15.24, the P/S ratio is 4.22 and the P/B ratio is finally 3.75. The dividend yield amounts to 3.03%.

Stock Charts:


Long-Term Stock Price Chart of T. Rowe Price Group (TROW)
Long-Term Stock Price Chart of T. Rowe Price Group (TROW)
Long-Term Dividend Payment History of T. Rowe Price Group (TROW)
Long-Term Dividend Payment History of T. Rowe Price Group (TROW)
Long-Term Dividend Yield History of T. Rowe Price Group (TROW)
Long-Term Dividend Yield History of T. Rowe Price Group (TROW)



Abbott Laboratories -- Yield: 2.78% RSI: 28.21

Abbott Laboratories (NYSE:ABT) employs 74,000 people, generates revenue of $20,405.00 million and has a net income of $2,606.00 million. The current market capitalization stands at $54.77 billion.

Abbott Laboratories’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4,434.00 million. The EBITDA margin is 21.73% (the operating margin is 14.05% and the net profit margin 12.77%).

Financials: The total debt represents 20.76% of Abbott Laboratories assets and the total debt in relation to the equity amounts to 40.37%. Due to the financial situation, a return on equity of 12.20% was realized by Abbott Laboratories.

Twelve trailing months earnings per share reached a value of $1.42. Last fiscal year, Abbott Laboratories paid $0.98 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 26.32, the P/S ratio is 2.69 and the P/B ratio is finally 2.60. The dividend yield amounts to 2.78%.

Stock Charts:


Long-Term Stock Price Chart of Abbott Laboratories (ABT)
Long-Term Stock Price Chart of Abbott Laboratories (ABT)
Long-Term Dividend Payment History of Abbott Laboratories (ABT)
Long-Term Dividend Payment History of Abbott Laboratories (ABT)
Long-Term Dividend Yield History of Abbott Laboratories (ABT)
Long-Term Dividend Yield History of Abbott Laboratories (ABT)



Cardinal Health -- Yield: 2.38% RSI: 29.32

Cardinal Health (NYSE:CAH) employs 34,500 people, generates revenue of $102,531.00 million and has a net income of $1,212.00 million. The current market capitalization stands at $24.27 billion.

Cardinal Health’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2,913.00 million. The EBITDA margin is 2.84% (the operating margin is 2.05% and the net profit margin 1.18%).

Financials: The total debt represents 18.22% of Cardinal Health assets and the total debt in relation to the equity amounts to 87.79%. Due to the financial situation, a return on equity of 19.15% was realized by Cardinal Health.

Twelve trailing months earnings per share reached a value of $4.18. Last fiscal year, Cardinal Health paid $1.37 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 18.04, the P/S ratio is 0.24 and the P/B ratio is finally 3.96. The dividend yield amounts to 2.38%.

Stock Charts:


Long-Term Stock Price Chart of Cardinal Health (CAH)
Long-Term Stock Price Chart of Cardinal Health (CAH)
Long-Term Dividend Payment History of Cardinal Health (CAH)
Long-Term Dividend Payment History of Cardinal Health (CAH)
Long-Term Dividend Yield History of Cardinal Health (CAH)
Long-Term Dividend Yield History of Cardinal Health (CAH)



Franklin Resources -- Yield: 2.16% RSI: 29.12

Franklin Resources (NYSE:BEN) employs 9,200 people, generates revenue of $7,948.70 million and has a net income of $2,104.70 million. The current market capitalization stands at $19.68 billion.

Franklin Resources’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3,129.30 million. The EBITDA margin is 39.37% (the operating margin is 37.96% and the net profit margin 26.48%).

Financials: The total debt represents 13.19% of Franklin Resources assets and the total debt in relation to the equity amounts to 18.20%. Due to the financial situation, a return on equity of 17.27% was realized by Franklin Resources.

Twelve trailing months earnings per share reached a value of $2.76. Last fiscal year, Franklin Resources paid $0.60 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.10, the P/S ratio is 2.45 and the P/B ratio is finally 1.70. The dividend yield amounts to 2.16%.

Stock Charts:


Long-Term Stock Price Chart of Franklin Resources (BEN)
Long-Term Stock Price Chart of Franklin Resources (BEN)
Long-Term Dividend Payment History of Franklin Resources (BEN)
Long-Term Dividend Payment History of Franklin Resources (BEN)
Long-Term Dividend Yield History of Franklin Resources (BEN)
Long-Term Dividend Yield History of Franklin Resources (BEN)



Sherwin-Williams -- Yield: 1.17% RSI: 39.18

Sherwin-Williams (NYSE:SHW) employs 40,706 people, generates revenue of $11,339.30 million and has a net income of $1,053.85 million. The current market capitalization stands at $26.46 billion.

Sherwin-Williams’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1,813.20 million. The EBITDA margin is 15.99% (the operating margin is 14.25% and the net profit margin 9.29%).

Financials: The total debt represents 33.74% of Sherwin-Williams assets and the total debt in relation to the equity amounts to 224.67%. Due to the financial situation, a return on equity of 112.57% was realized by Sherwin-Williams.

Twelve trailing months earnings per share reached a value of $11.36. Last fiscal year, Sherwin-Williams paid $2.68 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 25.38, the P/S ratio is 2.35 and the P/B ratio is finally 30.64. The dividend yield amounts to 1.17%.

Stock Charts:


Long-Term Stock Price Chart of Sherwin-Williams (SHW)
Long-Term Stock Price Chart of Sherwin-Williams (SHW)
Long-Term Dividend Payment History of Sherwin-Williams (SHW)
Long-Term Dividend Payment History of Sherwin-Williams (SHW)
Long-Term Dividend Yield History of Sherwin-Williams (SHW)
Long-Term Dividend Yield History of Sherwin-Williams (SHW)

2 comments:

  1. Thanks for sharing. I like ABT and TROW at these levels. ABT actually made my June considerations list but I went with ABBV instead this week. Still another week of June to go. Thanks for sharing.

    ReplyDelete
  2. Hi,

    I like BEN a lot at these levels, nevertheless I think you should consider cash in valuation. I know that in P/E ratio normally there is no need to deduct cash, but with piles of cash handled by BEN I think it might be useful (maybe they will pay some extra dividend)

    Best regards,
    DividendTIME

    ReplyDelete

Do you have any questions or notes to this article?
Please let me know your thoughts and we will discuss it.